标题
Controversies in the Therapy of Low-Grade Gliomas
作者
关键词
Low-grade glioma, Controversy, PCV, Temozolomide, IDH mutation
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 20, Issue 4, Pages -
出版商
Springer Nature
发表日期
2019-03-14
DOI
10.1007/s11864-019-0625-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis
- (2018) Javier E. Villanueva-Meyer et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis
- (2018) Liang Xia et al. BMC CANCER
- Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
- (2018) Erica H. Bell et al. JAMA Oncology
- Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
- (2018) Martin J van den Bent et al. LANCET ONCOLOGY
- Does early resection of presumed low-grade glioma improve survival? A clinical perspective
- (2017) Maarten M. J. Wijnenga et al. JOURNAL OF NEURO-ONCOLOGY
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS
- (2017) Erica H Bell et al. NEURO-ONCOLOGY
- Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
- (2016) Emeline Tabouret et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
- (2016) Brigitta G Baumert et al. LANCET ONCOLOGY
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
- (2016) Jan C. Buckner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proton therapy for low-grade gliomas: Results from a prospective trial
- (2015) Helen A. Shih et al. CANCER
- Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
- (2015) Barbara J. Fisher et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The role of surgery in the management of patients with diffuse low grade glioma
- (2015) Manish K. Aghi et al. JOURNAL OF NEURO-ONCOLOGY
- Neurocognitive effects of proton radiation therapy in adults with low-grade glioma
- (2015) Janet Cohen Sherman et al. JOURNAL OF NEURO-ONCOLOGY
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Neurocognitive Function Following Therapy for Low-Grade Gliomas
- (2015) Mary Frances McAleer et al. SEMINARS IN RADIATION ONCOLOGY
- Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
- (2015) Jane B. Cryan et al. Oncotarget
- Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
- (2014) Seunghyun Lee et al. JOURNAL OF NEURO-ONCOLOGY
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
- (2012) Asgeir S. Jakola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
- (2012) Edward G. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients
- (2012) Tamara Ius et al. JOURNAL OF NEUROSURGERY
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
- (2011) A. B. Lassman et al. NEURO-ONCOLOGY
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
- (2010) Martin J. van den Bent ACTA NEUROPATHOLOGICA
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Late neurocognitive decline after radiotherapy for low-grade glioma
- (2009) Mustafa Khasraw et al. Nature Reviews Neurology
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial
- (2008) Edward G. Shaw et al. JOURNAL OF NEUROSURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started